DTIL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Precision BioSciences Inc (DTIL) is not a strong buy at this moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading trends or signals to suggest a compelling entry point.
The MACD is positive but contracting, RSI is neutral at 65.213, and moving averages are converging, indicating a lack of strong directional momentum. The stock is trading near its pivot point of 4.264, with resistance levels at 4.695 and 4.962, and support levels at 3.832 and 3.565. Overall, technical indicators suggest a neutral trend.
NULL identified. No recent news, no significant insider or hedge fund activity, and no recent congress trading data.
The stock also lacks strong trading signals or momentum.
In Q3 2025, revenue dropped significantly by -97.74% YoY to $13,000. Net income improved slightly but remains negative at -$21.77M, and EPS declined to -1.84. Gross margin remains at 100%, but overall financials indicate poor growth and profitability trends.
No data on analyst ratings or price target changes is provided. Wall Street sentiment is unclear.
